Skip to main content
. Author manuscript; available in PMC: 2015 Dec 21.
Published in final edited form as: Clin Chem. 2015 Apr 28;61(6):877–884. doi: 10.1373/clinchem.2015.240051

Table 1.

Characteristics of Subset of HANDLS Participants Overall and by Race.

Characteristic Overall (N=376) Whites1 (N=164) Blacks1 (N=212) P-value
Age (y) 48.6 ± 9.2 49.3 ± 9.3 48.1 ± 9.1 0.18
Male sex (%) 166 (44.2) 72 (43.9) 94 (44.3) 0.93
Body Mass Index (kg/m2) 29.6 ± 7.6 30.1 ± 7.4 29.3 ± 7.8 0.31
Household income < 25% poverty line (%) 159 (42.3) 54 (32.9) 105 (49.5) 0.001
Current smoker (%) 176 (46.8) 74 (45.1) 102 (48.1) 0.45
Osteoporosis diagnosis (%) 12 (3.2) 9 (5.5) 3 (1.4) 0.04
Prescribed osteoporosis therapy (%) 10 (2.7) 6 (3.7) 4 (1.9) 0.29
Postmenopausal (% of women) 108 (51.4) 52 (56.5) 56 (47.5) 0.21
Prescribed HRT (% of women) 5 (2.4) 2 (2.2) 3 (2.5) 0.81
Microalbuminuria (%) 4 (1.1) 2 (1.2) 2 (0.9) 0.99
eGFR <60 ml/min/m2 (%) 26 (6.9) 9 (5.5) 17 (8.0) 0.35
Prescribed antiepileptic agents (%) 3 (0.8) 2 (1.2) 1 (0.5) 0.42
Prescribed glucocorticoids (%) 5 (1.3) 1 (0.6) 4 (1.9) 0.28
Dietary vitamin D intake (IU/day) 154 ± 181 164 ± 223 146 ± 141 0.37
Dietary calcium intake (mg/day) 745 ± 568 761 ± 601 732 ± 542 0.62
Femoral neck bone mineral density (g/cm2) 1.00 ± 0.19 0.95 ± 0.16 1.04 ± 0.19 <0.001
Serum calcium (mg/dL) 9.3 ± 0.4 9.3 ± 0.4 9.3 ± 0.4 0.63
Parathyroid hormone (pg/mL) 36 (29, 47) 34 (27, 45) 38 (30, 48) 0.01
25D3 (ng/mL) 21.6 ± 10.8 27.5 ± 11.3 17.0 ± 7.8 <0.001
24,25D3 (ng/mL) 2.7 ± 1.8 3.6 ± 2.0 2.1 ± 1.3 <0.001
VMR (24,25(OH)2D3/25D3 ratio) × 100 12.1 ± 3.7 12.5 ± 3.4 11.9 ± 4.0 0.16
1

There were no statistically significant differences between any of the characteristics of white HANDLS subjects included in this study compared to non-included whites, and no differences between included and non-included black HANDLS subjects.

HRT = hormone replacement therapy

Table shows means ± standard deviations,

median (quartile 1, quartile 3), or number (percentage).